Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Treg Cell Function in Rheumatoid Arthritis Is Compromised by CTLA‐4 Promoter Methylation Resulting in a Failure to Activate the Indoleamine 2,3‐Dioxygenase Pathway

Cribbs, Adam P., Kennedy, Alan, Penn, Henry, Read, Jordan E., Amjadi, Parisa, Green, Patricia, Syed, Khaja, Manka, Szymon W., Brennan, Fionula M., Gregory, Bernard, Williams, Richard O. · 2014 · Arthritis & Rheumatology

Abstract

Objective: Functionally impaired Treg cells expressing abnormally low levels of CTLA‐4 have been well documented in rheumatoid arthritis (RA). However, the molecular defect underlying this reduced expression is unknown. The aims of this study were to assess the role of DNA methylation in regulating CTLA‐4 expression in Treg cells isolated from RA patients and to elucidate the mechanism of their reduced suppressor function. Methods: CTLA‐4 expression in Treg cells from RA patients and healthy controls was measured by quantitative polymerase chain reaction (PCR) and flow cytometry. Methylation of the CTLA‐4 gene promoter was analyzed by bisulfite‐specific PCR, followed by sequencing. Methylation‐dependent transcriptional activity of the CTLA‐4 gene promoter was measured by luciferase assay, and NF‐AT binding to the CTLA‐4 gene promoter was determined by chromatin immunoprecipitation. The role of CTLA‐4 expression in controlling Teff cells was analyzed using an autologous mixed lymphocyte reaction. Results: Down‐regulation of CTLA‐4 expression in Treg cells from RA patients was caused by methylation of a previously unidentified NF‐AT binding site within the CTLA‐4 gene promoter. As a consequence, Treg cells were unable to induce expression and activation of the tryptophan‐degrading enzyme indoleamine 2,3‐dioxygenase (IDO), which in turn resulted in a failure to activate the immunomodulatory kynurenine pathway. Conclusion: We show for the first time that epigenetic modifications contribute to defective Treg cell function in RA through an inability to activate the IDO pathway. Therefore, this study sets a precedent for investigating potential therapeutic strategies aimed at reinforcing the IDO pathway in RA patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.38715

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 158

Metadata

Authors
Cribbs, A. P., Kennedy, A., Penn, H., Read, J. E., Amjadi, P., Green, P., Syed, K., Manka, S. W., Brennan, F. M., Gregory, B., & Williams, R. O.
Venue
Arthritis & Rheumatology
Publisher
Wiley
Published
2014-08-26
Volume
66
Issue
9
Pages
2344-2354
ISSN
  • 2326-5191 (ISSN-L)
  • 2326-5205
OpenAlex
W1620983111
Cited by
158
References
2
FWCI
11.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treg Cell Function in Rheumatoid Arthritis Is Compromised by CTLA‐4 Promoter Methylation Resulting in a Failure to Activate the Indoleamine 2,3‐Dioxygenase Pathway. https://app.cochat.ai/papers/10.1002/art.38715
The paper
Cribbs, A. P., Kennedy, A., Penn, H., Read, J. E., Amjadi, P., Green, P., Syed, K., Manka, S. W., Brennan, F. M., Gregory, B., & Williams, R. O. (2014). Treg Cell Function in Rheumatoid Arthritis Is Compromised by CTLA‐4 Promoter Methylation Resulting in a Failure to Activate the Indoleamine 2,3‐Dioxygenase Pathway. Arthritis & Rheumatology. https://doi.org/10.1002/art.38715

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.